The GT103 antibody (previously mAb7968), was derived from an anti-CFH autoantibody that is associated with an early stage, non-metastatic phenotype in non-small cell lung cancer (NSCLC) [14, 19, 20]. The gene discussed is CFH; the disease is non-small cell lung carcinoma.